Shanghai Haixin Group Co., Ltd.

600851

CNE000000CF1

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-30 pm EDT			5-day change	1st Jan Change
5.4 ^CNY	+0.19%		-3.91%	-21.40%

Apr. 26	Shanghai Haixin Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 19	Shanghai Haixin Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Shanghai Haixin Group Co., Ltd. Provides Earnings Guidance for the Year 2015

January 18, 2016

Shanghai Haixin Group Co., Ltd. provided earnings guidance for the year 2015. For the year, the company predicted a sharp decrease of 50% in the net profit belonging to shareholders of listed company compared with the same period of the year before.

Latest news about Shanghai Haixin Group Co., Ltd.

Shanghai Haixin Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 26	CI
Shanghai Haixin Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 19	CI
Shanghai Haixin Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Shanghai Haixin Group Co., Ltd.(XSSC:600851) added to S&P Global BMI Index	23-09-18	CI
Shanghai Haixin Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-25	CI
Shanghai Haixin Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Shanghai Haixin Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-27	CI
Shanghai Haixin Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Shanghai Haixin Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-19	CI
Shanghai Haixin Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-27	CI
Shanghai Haixin Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-18	CI
Shanghai Haixin Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-29	CI
Shanghai Haixin Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-20	CI
Shanghai Haixin Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-27	CI
Shanghai Haixin Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-20	CI
Shanghai Haixin Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	20-10-27	CI
Shanghai Haixin Group Co., Ltd.(SHSE:900917) dropped from FTSE All-World Index	20-09-21	CI
Shanghai Haixin Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020	20-08-27	CI
Shanghai Haixin Group Co., Ltd. Announces Cash Dividend Per A Share and B Share	20-07-23	CI
Shanghai Haixin Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-04-28	CI
Shanghai Haixin Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019	20-04-27	CI
Shanghai Haixin Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2019	19-10-27	CI
Shanghai Haixin Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2019	19-08-26	CI
Shanghai Haixin Group Co., Ltd. Announces Divined on Share A and B, Payable on July 29, 2019 and August 9, 2019	19-07-21	CI
Shanghai Haixin Group Co., Ltd. Announces Financial Results for First Quarter of 2019	19-04-25	CI

Chart Shanghai Haixin Group Co., Ltd.

Duration

Period

More charts

Company Profile

Shanghai Haixin Group Co., Ltd. is a China based company principally engaged in the production and sales of textile products and pharmaceuticals. The Company operates its business through two segments. The Textile segment is mainly engaged in the production and sales of plush fabric and clothing. The Pharmaceutical segment is mainly engaged in the manufacture and sales of pharmaceutical products. In addition, The Company is also engaged in financial investment business and industrial plant rental management business. The Company operates its business in the domestic market and overseas markets.

Sector

Pharmaceuticals

Calendar

2024-06-20 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
SHANGHAI HAIXIN GROUP CO., LTD.	-21.40%	645M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+15.37%	41.97B
OTSUKA HOLDINGS CO., LTD.	+22.56%	22.34B
SANDOZ GROUP AG	+15.30%	15.25B
CIPLA LIMITED	+16.53%	14B
ZYDUS LIFESCIENCES LIMITED	+49.78%	12.06B
ONO PHARMACEUTICAL CO., LTD.	-10.77%	6.8B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+14.18%	5.49B